Matthew Hamilton Rosenberg’s Teva Pharmaceuticals TEVA Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Hold	6,108	–	–	0.04%	221
2026 Q1	$184K	Hold	6,108	–	–	0.04%	228
2025 Q4	$191K	Hold	6,108	–	–	0.04%	214
2025 Q3	$123K	Hold	6,108	–	–	0.03%	289
2025 Q2	$102K	Hold	6,108	–	–	0.02%	324
2025 Q1	$93.9K	Hold	6,108	–	–	0.02%	326
2024 Q4	$135K	Hold	6,108	–	–	0.04%	256
2024 Q3	$110K	Hold	6,108	–	–	0.03%	306
2024 Q2	$99.8K	Hold	6,108	–	–	0.03%	296
2024 Q1	$85K	Hold	6,108	–	–	0.02%	339
2023 Q4	$63.8K	Hold	6,108	–	–	0.02%	389
2023 Q3	$62.3K	Hold	6,108	–	–	0.02%	384
2023 Q2	$46K	Buy	6,108 +1	+0%	+$8	0.02%	448
2023 Q1	$54K	Hold	6,107	–	–	0.02%	447
2022 Q4	$55.7K	Hold	6,107	–	–	0.02%	431
2022 Q3	$49K	Hold	6,107	–	–	0.02%	442
2022 Q2	$48K	Buy	6,107 +1,107	+22%	+$9.64K	0.02%	470
2022 Q1	$47K	Hold	5,000	–	–	0.02%	470
2021 Q4	$40K	Hold	5,000	–	–	0.01%	452
2021 Q3	$49K	Hold	5,000	–	–	0.02%	397
2021 Q2	$50K	Hold	5,000	–	–	0.03%	357
2021 Q1	$58K	Hold	5,000	–	–	0.03%	330
2020 Q4	$48K	Hold	5,000	–	–	0.03%	334
2020 Q3	$45K	Hold	5,000	–	–	0.03%	320
2020 Q2	$62K	Hold	5,000	–	–	0.05%	276
2020 Q1	$45K	Buy	+5,000	New	+$51.2K	0.04%	274

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Matthew Hamilton Rosenberg's TEVA Position: Q2 2026 in Review

Matthew Hamilton Rosenberg held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 6,108 shares worth $207K. The position accounts for 0.04% of the portfolio, ranked #221.

Matthew Hamilton Rosenberg first reported a position in TEVA in Q1 2020 and has held it in 26 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Matthew Hamilton Rosenberg held 6,108 shares of Teva Pharmaceuticals worth $207K as of Q2 2026.
Matthew Hamilton Rosenberg left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.04% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #221 holding.
Matthew Hamilton Rosenberg first reported a position in Teva Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.